3

MAIN DOCUMENT DESCRIPTION

Company: Vanda Pharmaceuticals Inc.
Filed: April 12, 2006
Period of Report: April 12, 2006
Accession Number: 0001209191-06-023610

View Document ↗ View on SEC.gov ↗